프레스티지바이오파마

950210KOSPI자연과학 및 공학 연구개발업

39.5 / 100

Reference Date: 2026-04-13

Financial Score11.5 / 40

News Sentiment14.0 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PER raises overvaluation concerns, ROE is below the industry average. Declined 6.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Prestige BioPharma is a biopharmaceutical company specializing in biosimilars and monoclonal antibody drug development. Its Herceptin biosimilar HD201 received a positive opinion from the European Medicines Agency (EMA) in 2024, while Avastin biosimilar HD204 and Humira biosimilar PBP1502 are in development. The company's pancreatic cancer treatment antibody drug PBP1510 holds patents in 13 countries, and its CTHRC1-targeting antibody drug PBP1710 is also in development.

Number of Employees

67people

Average Salary

53.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

184675.06Industry Average 120.070.0Point

1538.1x industry avg (risky)

PBR

—Industry Average 3.823.5Point

ROE

0.80Industry Average -32.113.5Point

Well below industry avg

Debt Ratio

14.17Industry Average 7.520.5Point

1.9x industry avg (risky)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲1098.9% (2-year basis)

Operating Profit Growth Rate

1.0 / 3

Avg ▲4.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -4.9% (improving, 2yr)

Detailed News Sentiment

5 totalPositive 1Neutral 3Negative 1Average Sentiment Score 56

Negative
프레스티지바이오파마 1000억 CB 발행 '난항'…지원 나선 키움증권
프레스티지바이오파마가 1000억원 규모의 전환사채(CB) 발행에 난항을 겪고 있으며, 발행 규모 축소 및 주관사 변경에도 불구하고 투자자 모집에 어려움을 겪고 있습니다.
Neutral
RNA·바이오시밀러·ADC…모멘텀 살아난 K바이오[바이오맥짚기]
RNA, 바이오시밀러, ADC 등 차세대 모달리티에 대한 기대감과 기술수출 성과로 K바이오 시장의 주요 종목들이 강세를 보이고 있다는 내용입니다.
Positive
프레스티지바이오파마, 아바스틴 시밀러 상용화 초읽기...‘13조 시장....
프레스티지바이오파마가 10조원 규모의 아바스틴 시밀러 상업화에 본격 시동을 걸며, 허셉틴 바이오시밀러 '투즈뉴'와 함께 주요 캐쉬카우로 성장할 것으로 전망됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 9,140Won52-week high 19,91052-week low 9,110

1-month return2.0Point

1m -6.16% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0